Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Shan Chen, MD, Ke Zhao, MD, Ren Lin, MD, Shunqing Wang, Zhiping Fan, MD, Fen Huang, MD, Xiaoyong Chen, PhD, Danian Nie, MD, Xin Du, MD, Ziwen Guo, MD, Dongjun Lin, MD, Li Xuan, MD, Na Xu, MD, Jing Sun, MD, Andy Peng Xiang, PhD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 871.

https://doi.org/10.1182/blood-2019-124455

Published: 2019

Journal Articles

Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

Lunqing Zhang, Mingjie Zhang, Xin Du, MD, Yunfeng Cheng, MD PhD, Gregory Cheng, MD PhD

Blood (2018) 132 (Supplement 1): 733.

https://doi.org/10.1182/blood-2018-99-111584

Published: 2018

Journal Articles

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Xiaojian Zhu, Yong You, PhD, Yicheng Zhang, MD PhD, Minghui Duan, MD, Yu Zhu, MD PhD, Bingcheng Liu, MD, Xin Du, MD, Suning Chen, PhD

Blood (2018) 132 (Supplement 1): 5443.

https://doi.org/10.1182/blood-2018-99-113854

Published: 2018

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Ultra-Deep Sequencing Leads to Earlier and More Sensitive Detection of Known or Novel Mutations of BCR-ABL1 in Chronic Myeloid Leukemia

Hongli Xiao, Heng Wang, Jin Lou, master, Weihong Chen, MD, Qiaoxia Zhang, PhD, Xin Du, MD

Blood (2018) 132 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2018-99-113728

Published: 2018

Journal Articles

MXD1 Regulates the Imatinib Resistance of Chronic Myeloid Leukemiacells By Repressing BCR-ABL1 Expression

Huan Chen, Jin Lou, master, Heng Wang, Na An, Yuming Pan, Weihong Chen, MD, Xin Du, MD, Qiaoxia Zhang, PhD

Blood (2018) 132 (Supplement 1): 5119.

https://doi.org/10.1182/blood-2018-99-113362

Published: 2018

Journal Articles

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Chen Xiaomei, Jianyu Weng, MD, Peilong Lai, Xin Huang, Wang Yulian, Suxia Geng, Liyan Guo, Tian Huang, Lingji Zeng, Xin Du, MD PhD

Blood (2018) 132 (Supplement 1): 5680.

https://doi.org/10.1182/blood-2018-99-114556

Published: 2018

Journal Articles

Establishment and Evaluation of Gvhd Mouse Model for Allogeneic Hematopoietic Stem Cell Transplantation

Mei Xie, Master, Weihong Chen, MD, Qiaoxia Zhang, PhD, Xin Du, MD

Blood (2018) 132 (Supplement 1): 5681.

https://doi.org/10.1182/blood-2018-99-112486

Published: 2018

Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Blood (2018) 132 (Supplement 1): 5637.

https://doi.org/10.1182/blood-2018-99-116844

Published: 2018

Journal Articles

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Jun Ma, MD, Ting Liu, MD, Jie Jin, MD PhD, Jianda Hu, MD PhD, Qifa Liu, MD, Jianxiang Wang, MD, Zhixiang Shen, MD, Xin Du, MD PhD, Bin Jiang, MD, Xianhua Meng, PhD

Blood (2016) 128 (22): 5198.

https://doi.org/10.1182/blood.V128.22.5198.5198

Published: 2016

Journal Articles

Arsenic Trioxide As a Front-Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia

Weihong Chen, MD, Xin Du, MD, Jiacai Zhuo, MD

Blood (2015) 126 (23): 4937.

https://doi.org/10.1182/blood.V126.23.4937.4937

Published: 2015

Journal Articles

a Proposal for a New Staging System of Extranodal Natural Killer T-cell Lymphoma, Nasal-Type: a Multicenter Study of Chinese Southwest Oncology Group (CSWOG)

Blood (2014) 124 (21): 4444.

https://doi.org/10.1182/blood.V124.21.4444.4444

Published: 2014

Journal Articles

Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)

Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiaoyan Ke, MD PhD, Xiao Li, MD PhD, Depei Wu, MD, Fanyi Meng, MD, Dena DeMarco, Jingshan Zhang, PhD, Jay Mei, MD, Jian Hou, MD PhD

Blood (2014) 124 (21): 5737.

https://doi.org/10.1182/blood.V124.21.5737.5737

Published: 2014

Journal Articles

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Renchi Yang, MD, Ming Hou, MD, Junmin Li, MD PhD, Jie Jin, MD, Meijuan Huang, MD, Ziqiang Yu, MD, Xiaojun Xu, Xiaohui Zhang, Xin Du, MD, Ting Niu, MD PhD, Xiaoyan Ke, MD PhD, Jianmin Wang, MD PhD, Jing Liu, MD, Jing Sun, MD, Yongqiang Zhao, MD& PhD, Hua Lu, MD, Haiyi Guo, MD, Belinda Hsu, Senior statistician

Blood (2014) 124 (21): 1464.

https://doi.org/10.1182/blood.V124.21.1464.1464

Published: 2014

Journal Articles

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

Jie Jin, MD, Xin Du, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jianmin Wang, MD, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jian Hou, MD, PhD

Blood (2013) 122 (21): 3227.

https://doi.org/10.1182/blood.V122.21.3227.3227

Published: 2013

Journal Articles

CD8α + Jagged2 high CD11b high Regulatory Dendritic Cells Prevent Acute Gvhd

Jianyu Weng, M.D., Xin Huang, Ping Wu, Peilong Lai, Yueying Li, M.D., Lin Xu, M.D., Suxia Geng, Xin Du, MD

Blood (2013) 122 (21): 5428.

https://doi.org/10.1182/blood.V122.21.5428.5428

Published: 2013

Journal Articles

A New Murine Model Of Chronic Graft Versus Host Disease

Xin Huang, Jianyu Weng, M.D., Ping Wu, Jiaqi Tong, Peilong Lai, Suxia Geng, Xin Du, MD

Blood (2013) 122 (21): 5429.

https://doi.org/10.1182/blood.V122.21.5429.5429

Published: 2013

Journal Articles

Single Arm, Multi-Center, Phase II Study Of Clofarabine In Chinese Pediatric Patients With Refractory Or Relapsed Acute Lymphoblastic Leukemia

Leping Zhang, Xin Du, MD, Yan Li, MD, Zhen Cai, MD, PhD, Kang Yu, MD, Fenlai Tan, MD, PhD, Yi Fang, MD, Xiaojun Huang, MD, Jin Lu, MD

Blood (2013) 122 (21): 5016.

https://doi.org/10.1182/blood.V122.21.5016.5016

Published: 2013

Journal Articles

Efficacy and Safety Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment: MM-021 Subgroup Analysis

Dao-bin Zhou, MD, Li Yu, MD, Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jianmin Wang, MD, Jian Hou, MD, PhD

Blood (2013) 122 (21): 5374.

https://doi.org/10.1182/blood.V122.21.5374.5374

Published: 2013

Journal Articles

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Chul Won Jung, MD, PhD, Lee-Yung Shih, MD, Zhijian Xiao, MD, Jie Jin, MD, Hsin-An Hou, MD, Xin Du, MD, Ming-Chung Wang, MD, Seonyang Park, MD, PhD, Ki-Seong Eom, MD, PhD, Kenji Oritani, Shinichiro Okamoto, MD, PhD, Tetsuzo Tauchi, MD, Jin Seok Kim, MD, Daobin Zhou, MD, Andres Sirulnik, MD, PhD, Wanda Ruiz, PhD, Taro Amagasaki, PhD, Kazuo Ito, Koichi Akashi, MD, PhD

Blood (2013) 122 (21): 4086.

https://doi.org/10.1182/blood.V122.21.4086.4086

Published: 2013

NARROW

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Ultra-Deep Sequencing Leads to Earlier and More Sensitive Detection of Known or Novel Mutations of BCR-ABL1 in Chronic Myeloid Leukemia

MXD1 Regulates the Imatinib Resistance of Chronic Myeloid Leukemiacells By Repressing BCR-ABL1 Expression

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Establishment and Evaluation of Gvhd Mouse Model for Allogeneic Hematopoietic Stem Cell Transplantation

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Arsenic Trioxide As a Front-Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia

a Proposal for a New Staging System of Extranodal Natural Killer T-cell Lymphoma, Nasal-Type: a Multicenter Study of Chinese Southwest Oncology Group (CSWOG)

Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

CD8α + Jagged2 high CD11b high Regulatory Dendritic Cells Prevent Acute Gvhd

A New Murine Model Of Chronic Graft Versus Host Disease

Single Arm, Multi-Center, Phase II Study Of Clofarabine In Chinese Pediatric Patients With Refractory Or Relapsed Acute Lymphoblastic Leukemia

Efficacy and Safety Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment: MM-021 Subgroup Analysis

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only